spacer
home > pmps > autumn 2017 > reduce, reuse, recycle
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Reduce, Reuse, Recycle

Faced with rising volumes of regulations, such as new Good Distribution Practices, pharmaceutical laboratories and their partners (clinical trial and logistics operators or specialists in the last mile of the cold chain) are looking for more efficient packaging solutions. Product ranges require temperature-controlled transportation, and the demand in this area is continually on the rise.

Tight Budgetary Restrictions

All these imperatives – and tight budget controls, in particular – are prompting purchasing and logistics departments in the cold chain to permanently optimise their transport costs. One upshot of this trend has been the shift from active to passive systems observed in recent years.

Passive isothermal packaging is cheaper, lighter and more flexible and currently offers such high standards of performance that the use of active isothermal packaging no longer makes any economic sense for certain destinations.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Yann Martin is the global sales director for EMBALL'ISO Group and its eight productions sites worldwide. He works with its team to support the pharma shippers and logistics providers to implement global temperature-controlled solutions. Over the past few years, Yann has driven the introduction of new business models in the company and market, such as rental, reverse logistics and ready-to-use services. Before taking these responsibilities, he worked on the technical side as Manager of the validation department and product design department. Yann holds a master’s degree in engineering from Polytech’Savoie, France. 
spacer
Yann Martin
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Aptus Clinical enters into a global partnership agreement with Artelo Biosciences

We are delighted to announce that Aptus Clinical has entered into an agreement with Artelo Biosciences to provide clinical development support the re-purposing of its high-potency dual cannabinoid agonist ART27.13 in oncology.
More info >>

White Papers

How to Reduce Costs of Specialty Pharmaceutical Shipments and Increase Patient Satisfaction

Temptime Corporation

The specialty pharmacy industry could reduce costs by $27.5 million annually (product and call center staff costs only) if visual temperature indicators were used as decision-making tools to determine if medicine should be used or returned when patients suspect heat damage. In addition, 97% of patients surveyed, who received medicine from specialty pharmacies with a visual temperature indicator included in the package, agree that they would want an indicator in all shipments and 95% agree the indicator increased their confidence in the medicines received.
More info >>

 
Industry Events

RDD Asia 2018

14-15 November 2018, Grand Hyatt Kochi, Kerala, India

A must-attend meeting for pulmonary and nasal researchers, inhaled product developers and vendors active in this important pharmaceutical niche.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement